Reports Full-Year Diluted EPS of $2.39 on a GAAP Basis, a Decrease of 12.1 Percent; Adjusted Diluted EPS of $10.12, a Decrease of 8.9 Percent; These Results Include an Unfavorable Impact of $1.52 Per Share Related to 2024 Acquired IPR&D and Milestones Expense Delivers Full-Year Net...
Hence then, the article about abbvie reports full year and fourth quarter 2024 financial results was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( AbbVie Reports Full-Year and Fourth-Quarter 2024 Financial Results )
Also on site :
- Police: Two killed in shooting at West San Jose shopping center
- Judge Rules That ICE Agents Violate the Fourth Amendment by Making Arrests While Masked
- Google’s new 1.9GW clean energy deal includes massive 100-hour battery